New approaches to establish genetic causality
- PMID: 25864169
- PMCID: PMC4560679
- DOI: 10.1016/j.tcm.2015.02.013
New approaches to establish genetic causality
Abstract
Cardiovascular medicine has evolved rapidly in the era of genomics with many diseases having primary genetic origins becoming the subject of intense investigation. The resulting avalanche of information on the molecular causes of these disorders has prompted a revolution in our understanding of disease mechanisms and provided new avenues for diagnoses. At the heart of this revolution is the need to correctly classify genetic variants discovered during the course of research or reported from clinical genetic testing. This review will address current concepts related to establishing the cause and effect relationship between genomic variants and heart diseases. A survey of general approaches used for functional annotation of variants will also be presented.
Copyright © 2015 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Determining pathogenicity in cardiac genetic testing: Filling in the blank spaces.Trends Cardiovasc Med. 2015 Oct;25(7):653-4. doi: 10.1016/j.tcm.2015.03.004. Epub 2015 Mar 6. Trends Cardiovasc Med. 2015. PMID: 25850977 No abstract available.
References
-
- Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12:745–755. - PubMed
-
- Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26:1135–1145. - PubMed
-
- Ingles J, Sarina T, Yeates L, Hunt L, Macciocca I, McCormack L, et al. Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy. Genet Med. 2013;15:972–977. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
